A Study on Mandurathi Kudineer in the management of Kaleeral Noi (Non-Alcoholic Fatty Liver Disease).
Phase 2
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2024/06/068735
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Participants with USG findings suggestive of fatty liver grades I , II, III showing fatty infiltration of the liver
Exclusion Criteria
1.Participants who are known to consume alcohol[alcohol history taken from participants close relatives]
2.k/c/o chronic kidney diseases, cardiovascular diseases
3.Participants with known liver diseases such as viral hepatitis, autoimmune disorders, biliary disorder, liver abscess, cirrhosis and malignancy
4.Pregnant and lactating women.
5.Participants who have taken drugs that interfere with the lipid metabolism within 3 months before screening such as methotrexate,sodium valporate,amiodarone and glucocorticoids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the Grades of fatty liver will be assessed by Ultra Sonogram before and after treatment.Timepoint: 6 MONTHS
- Secondary Outcome Measures
Name Time Method 1.Changes in Liver function test,lipid profile and fasting blood sugar will be assessed before and after treatment <br/ ><br>2.Changes in waist circumference and Body Mass Index will be assessed before and after treatment <br/ ><br> <br/ ><br> <br/ ><br>Timepoint: 6 MONTHS